CAS: 311772-46-0; γ3,γ6,γ9-Tricarboxy-3,6,9,15-Tetraazabicyclo[9.3.1]Pentadeca-1(15),11,13-Triene-3,6,9-Tributanoic Acid

主要参考文献

1: Somnin C, Chamieh J, Leclercq L, Medina C, Rousseaux O, Cottet H. Interaction study between gadolinium-based contrast agents and lysozyme using frontal analysis continuous capillary electrophoresis. Anal Chim Acta. 2025 Oct 22;1372:344433. doi: 10.1016/j.aca.2025.344433. Epub 2025 Jul 14.
191:112322. doi: 10.1016/j.ejrad.2025.112322. Epub 2025 Jul 16. ESMRMB-GREC Working Group; ESNR. Recommendations on the use of gadolinium-based contrast agents in the diagnosis and monitoring of common adult intracranial tumours. Eur Radiol. 2025 Jun 6. doi: 10.1007/s00330-025-11646-6. Epub ahead of print. 13(4):829. doi: 10.3390/biomedicines13040829.
11: Frenzel T, Wels T, Pietsch H, Schöckel L, Seidensticker P, Endrikat J. Recent Developments and Future Perspectives in Magnetic Resonance Imaging and Computed Tomography Contrast Media. Invest Radiol. 2025 Apr 1. doi: 10.1097/RLI.0000000000001180. Epub ahead of print. 12(14):e2415321. doi: 10.1002/advs.202415321. Epub 2025 Feb 17.